169 results on '"Froud T"'
Search Results
2. Effect of Exenatide on Gastric Emptying and Graft Survival in Islet Allograft Recipients
Catalog
Books, media, physical & digital resources
3. Combined Islet and Hematopoietic Stem Cell Allotransplantation: A Clinical Pilot Trial to Induce Chimerism and Graft Tolerance
4. Simple Measures to Monitor b -Cell Mass and Assess Islet Graft Dysfunction
5. Continuous Glucose Monitoring System for Early Detection of Graft Dysfunction in Allogenic Islet Transplant Recipients
6. Simple Measures to Monitor β-Cell Mass and Assess Islet Graft Dysfunction
7. Cytomegalovirus Infection in a Recipient of Solitary Allogeneic Islets
8. Quality of Life After Islet Transplantation
9. Abstract No. 494 Microwave ablation zone observations in a large series with recommendations for adjustments
10. C-Peptide and Glucose Values in the Peritransplant Period After Intraportal Islet Infusions in Type 1 Diabetes
11. Nationwide analysis of hospital characteristics, demographics, and cost of uterine fibroid embolization
12. Percutaneous irreversible electroporation (IRE) in the management of pancreatic cancer
13. Splenic artery embolization for Thrombocytopenia in Chemotherapy Recipients
14. Percutaneous microwave ablation therapy in management of hepatic tumors. A single- center experience
15. Abstract No. 8: Downstaging locally advanced pancreatic adenocarcinoma (LAPC) with vascular encasement using percutaneous irreversible electroporation (IRE)
16. Late Epstein Barr Virus Reactivation in Islet After Kidney Transplantation
17. HYPOGLYCEMIA AWARENESS AFTER ISLET TRANSPLANTATION
18. USE OF ACETAMINOPHEN LEVEL TESTING DURING MIXED MEAL STIMULATION IN ISLET TRANSPLANT RECIPIENTS USING EXENATIDE
19. RECURRENCE OF AUTOIMMUNITY IN ISLET ALLOTRANSPLANT RECIPIENTS EVALUATED BY GAD65 AND IA2 AUTOANTIBODIES
20. LONG TERM INSULIN INDEPENDENCE AND RESTORATION OF FIRST PHASE INSULIN RELEASE AFTER SUPPLEMENTAL ISLET INFUSION UNDER EXENATIDE TREATMENT IN SUBJECTS WITH ISLET GRAFT DYSFUNCTION
21. LATE EPSTEIN BARR VIRUS REACTIVATION IN ISLET TRANSPLANT RECIPIENTS
22. IMPROVED LONG-TERM HEALTH RELATED QUALITY OF LIFE AFTER ISLET TRANSPLANTATION: A 6-YEAR FOLLOW-UP STUDY
23. KIDNEY FUNCTION AFTER CLINICAL ISLET TRANSPLANTATION
24. DEFINING THE IMMUNE RESPONSE LEVELS IN ISLET ALLOTRANSPLANTATION BY THE IMMUNE CELL FUNCTION ASSAY IMMUKNOWTM CYLEX®
25. COMBINED ISLET AND HEMATOPOIETIC STEM CELL ALLOTRANSPLANTATION: A CLINICAL PILOT TRIAL TO INDUCE CHIMERISM AND GRAFT TOLERANCE
26. USE OF ALEMTUZUMAB INDUCTION AND CALCINEURIN-FREE LONG TERM IMMUNOSUPPRESSION TO IMPROVE SHORT AND LONG TERM OUTCOMES IN ISLET TRANSPLANTATION.
27. LONG-TERM METABOLIC AND HORMONAL EFFECTS OF EXENATIDE ON ISLET TRANSPLANT RECIPIENTS WITH ALLOGRAFT DYSFUNCTION
28. Abstract No. 454 - Nationwide analysis of hospital characteristics, demographics, and cost of uterine fibroid embolization
29. Cryogenic mounts for large fused silica lenses
30. EVALUATION OF AUTOANTIBODY LEVELS IN PATIENTS UNDERGOING ISLET TRANSPLANTATION
31. INSULIN INDEPENDENCE FOLLOWING TRANSPLANTATION OF CULTURED HUMAN ISLETS IN PATIENTS WITH TYPE 1 DIABETES: THE MIAMI EXPERIENCE
32. ACUTE INSULIN RELEASE TO INTRAVENOUS GLUCOSE IS THE BEST INDICATOR OF ISLET ALLOGRAFT DYSFUNCTION.
33. GYNECOLOGICAL ALTERATIONS IN TRANSPLANTED PATIENTS: SINGLE CENTER EXPERIENCE IN PATIENTS WITH TYPE 1 DIABETES FOLLOWING ISLET CELL TRANSPLANTATION.
34. PORTAL PRESSURE CHANGES OBSERVED IN PATIENTS RECEIVING THREE OR MORE ISLET INFUSIONS
35. IMMUNOSUPPRESSION-RELATED COMPLICATIONS IN 26 PATIENTS USING A STEROID FREE REGIMEN IN ISLET CELL TRANSPLANTATION
36. CMV, EBV AND PARVOVIRUS STATUS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS AWAITING ISLET CELL TRANSPLANTATION
37. INSULIN INDEPENDENCE FOLLOWING TRANSPLANTATION OF CULTURED HUMAN ISLETS IN PATIENTS WITH TYPE 1 DIABETES
38. EVALUATION OF ISLET ALLOGRAFT FUNCTION IN TYPE 1 DM PATIENTS FOLLOWING INTRAHEPATIC ISLET CELL TRANSPLANTATION
39. Acute and Chronic Imaging Findings in Patients with Intrahepatic Islet Transplants
40. Title: Islet After Kidney Transplantation Revisited
41. Improvement in Islet Graft function Following Removal of Tacrolimus from the Immunosuppressive Regimen in a Single Islet Transplant Recipient.
42. The UK FMOS spectrograph.
43. 4:42 PM; Abstract No. 63 - Percutaneous irreversible electroporation (IRE) in the management of pancreatic cancer
44. Abstract No. 356 - Percutaneous microwave ablation therapy in management of hepatic tumors. A single- center experience
45. Abstract No. 260 - Splenic artery embolization for thrombocytopenia in chemotherapy recipients
46. Pain Analysis in Patients with Hepatocellular Carcinoma: Irreversible Electroporation versus Radiofrequency Ablation-Initial Observations.
47. Simple Measures to Monitor ?-Cell Mass and Assess Islet Graft Dysfunction
48. Twenty years of clinical islet transplantation at the Diabetes Research Institute--University of Miami
49. DEFINING THE IMMUNE RESPONSE LEVELS IN ISLET ALLOTRANSPLANTATION BY THE IMMUNE CELL FUNCTION ASSAY IMMUKNOWTM CYLEX®.
50. EVALUATION OF THE PERCUTANEOUS TRANSHEPATIC INTRAPORTAL METHOD OF ISLET CELL TRANSPLANTATION.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.